Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas

Summary

The purpose of this study is to evaluate whether therapy with farletuzumab is effective and safe in the treatment of resectable, non-functioning pituitary adenomas.

Timeline

Start

2011-02

Primary completion

2013-06

Completion

2013-08

Outcome

Outcome not reported

Stopped: “Trial terminated due to focus of primary therapeutic areas.”

Drugs

Indications